Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 477
Filter
1.
J Homosex ; 68(13): 2301-2321, 2021 Nov 10.
Article in English | MEDLINE | ID: mdl-32154767

ABSTRACT

Homonegativity research tends to focus on the identities of gay men and lesbian women through inauthentic means such as vignettes and signifiers like t-shirts with pro-gay slogans. Such research also tends to neglect sexual behavior. These issues were addressed in the present mixed-methods study. Heterosexual male (n = 196) and female (n = 219) participants were asked to complete measures of old-fashioned and modern homonegativity toward gay men and lesbian women after viewing a set of stimuli depicting gay male, lesbian female, or heterosexual couples. Participants also completed an interview with the researcher where he self-identified as a gay male and observed any changes in behavior following his disclosure. Findings indicated that male participants showed higher levels of modern homonegativity than female participants, regardless of the images viewed, and had higher odds of exhibiting negative behavioral change in response to the researcher's self-disclosure. Also, participants who viewed images of lesbian couples kissing or embracing had lower odds of showing negative behavioral change.


Subject(s)
Homosexuality, Female , Sexual and Gender Minorities , Female , Heterosexuality , Homosexuality, Male , Humans , Male , Sexual Behavior
2.
Eur J Appl Physiol ; 120(7): 1681-1688, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32472418

ABSTRACT

PURPOSE: The purpose of the present study was to investigate the influence of strength outcome [maximal voluntary contraction (MVC) torque vs. rate of torque development (RTD)], motor task (unilateral vs. bilateral) and muscle group (knee extensors vs. flexors) on the magnitude of bilateral deficits and inter-limb asymmetries in a large heterogeneous group of athletes. METHODS: 259 professional/semi-professional athletes from different sports (86 women aged 21 ± 6 years and 173 men aged 20 ± 5 years) performed unilateral and bilateral "fast and hard" isometric maximal voluntary contractions of the knee extensors and flexors on a double-sensor dynamometer. Inter-limb asymmetries and bilateral deficits were compared across strength outcomes (MVC torque and multiple RTD measures), motor tasks and muscle groups. RESULTS: Most RTD outcomes showed greater bilateral deficits than MVC torque for knee extensors, but not for knee flexors. Most RTD outcomes, not MVC torque, showed higher bilateral deficits for knee extensors compared to knee flexors. For both muscle groups, all RTD measures resulted in higher inter-limb asymmetries than MVC torque, and most RTD measures resulted in greater inter-limb asymmetries during unilateral compared to bilateral motor tasks. CONCLUSIONS: The results of the present study highlight the importance of outcome measure, motor task and muscle group when assessing bilateral deficits and inter-limb asymmetries of maximal and explosive strength. Compared to MVC torque and bilateral tasks, RTD measures and unilateral tasks could be considered more sensitive for the assessment of bilateral deficits and inter-limb asymmetries in healthy professional/semi-professional athletes.


Subject(s)
Isometric Contraction/physiology , Muscle Strength/physiology , Muscle, Skeletal/physiology , Outcome Assessment, Health Care , Adolescent , Adult , Athletes , Female , Humans , Knee Joint/physiology , Male , Quadriceps Muscle/physiology , Young Adult
4.
J Soc Psychol ; 160(3): 310-323, 2020 May 03.
Article in English | MEDLINE | ID: mdl-31405346

ABSTRACT

When examining negative attitudes and behaviors directed toward gay men and lesbian women (i.e., homonegativity), researchers tend to use measures that require participants to respond to belief statements. This methodology is problematic for two reasons: 1) it focuses on the social categories "gay men" and "lesbian women" and ignores the practices of relational intimacy engaged in by gay and lesbian persons (practices that, arguably, are at the crux of homonegativity); and 2) it overlooks the affective responses that sexual minorities evoke in heterosexual people. These issues were tackled in the current study. Specifically, heterosexual participants (N = 241) were asked to report their affective state using six basic emotions while viewing photos depicting male-male, female-female, and heterosexual couples. Findings demonstrated that participants, regardless of gender, reacted most negatively to images of female-female couples engaging in everyday intimacies. Theoretical explanations for these findings are explored.


Subject(s)
Affect/physiology , Heterosexuality/psychology , Homophobia/psychology , Homosexuality, Female/psychology , Homosexuality, Male/psychology , Sexual Partners/psychology , Sexual and Gender Minorities/psychology , Social Perception , Visual Perception , Adult , Female , Humans , Male
5.
J Phys Chem Lett ; 10(14): 4069-4075, 2019 Jul 18.
Article in English | MEDLINE | ID: mdl-31269793

ABSTRACT

Spectroscopic ellipsometry was used to characterize vapor-deposited glasses of ethylbenzene (Tg = 115.7 K). For this system, previous calorimetric experiments have established that a transition to the ideal glass state is expected to occur near 101 K (the Kauzmann temperature, TK) if the low-temperature supercooled liquid has the properties expected based upon extrapolation from above Tg. Ethylbenzene glasses were vapor-deposited at substrate temperatures between 100 (∼0.86 Tg) and 116 K (∼Tg), using deposition rates of 0.02-2.1 nm/s. Down to 103 K, glasses prepared in the limit of low deposition rate have densities consistent with the extrapolated supercooled liquid. The highest density glass is within 0.15% of the density expected for the ideal glass. These results support the hypothesis that the extrapolated properties of supercooled ethylbenzene are correct to within just a few Kelvin of TK, consistent with the existence of a phase transition to an ideal glass state at TK.

6.
J Homosex ; 66(4): 549-570, 2019.
Article in English | MEDLINE | ID: mdl-29308989

ABSTRACT

Prejudice and discrimination against LGBT individuals is widespread and has been shown to have negative consequences for sexual and gender minority persons' physical and psychological wellbeing. A recent and problematic trend in the literature is to compositely measure prejudice toward and discrimination against LGBT persons. As such, a review of the psychometric properties of scales assessing, in a combinatory fashion, negative attitudes and/or behaviors toward LGBT persons is warranted. In the current study, 32 scales were identified, and their psychometric properties were evaluated. Most of the scales reviewed did not provide sufficient information regarding item development and refinement, scale dimensionality, scale score reliability, or validity. Properties of the reviewed scales are summarized, and recommendations for better measurement practice are articulated.


Subject(s)
Prejudice , Sexual and Gender Minorities , Bisexuality/psychology , Female , Homophobia , Humans , Male , Psychometrics , Reproducibility of Results , Transgender Persons/psychology
7.
J Homosex ; 66(7): 1014-1033, 2019.
Article in English | MEDLINE | ID: mdl-29920167

ABSTRACT

Using a combination of personal reflections, published literature, and original empirical research, we argue that the disgust triggered by gay men's sexual practices (specifically, anal intercourse) is a critical, though overlooked, contributor to heterosexual men and women's homonegativity (i.e., negative attitudes and behaviors directed toward men who are or are perceived to be gay). We conclude our article by articulating several directions for future inquiry that we believe will advance current understanding of prejudice and discrimination directed toward gay men.


Subject(s)
Disgust , Heterosexuality/psychology , Homophobia/psychology , Homosexuality, Male , Sexual Behavior , Adult , Fear , Female , Humans , Male , Middle Aged , Prejudice
8.
Hum Reprod ; 33(4): 694-705, 2018 04 01.
Article in English | MEDLINE | ID: mdl-29401269

ABSTRACT

STUDY QUESTION: What are the impacts of elevated testosterone (T) and an obesogenic western-style diet (WSD), either independently or together, on fertility and metabolic adaptations of pregnancy in primates? SUMMARY ANSWER: Testosterone increases the time to achieve pregnancy, while a WSD reduces overall fertility, and the combination of testosterone and WSD additionally impairs glucose tolerance and causes pregnancy loss. WHAT IS KNOWN ALREADY: Both hyperandrogenemia and obesity are hallmarks of polycystic ovary syndrome, which is a leading cause of infertility among women worldwide. Female macaques receiving T and WSD beginning at puberty show increased metabolic, ovarian and uterine dysfunction in the non-pregnant state by 3 years of treatment. STUDY DESIGN, SIZE, DURATION: The same cohort of female rhesus macaques continued treatments from the time of puberty (2.5 years) to 4 years, including this fertility trial. There were four groups (n = 9-10/group): controls (C), T-treated (T; average total serum level 1.35 ng/ml), WSD-treated, and combined T and WSD-treated (T + WSD) females. PARTICIPANTS/MATERIALS, SETTING, METHODS: Females, which were typically having menstrual cycles, were paired for 4 days with a proven male breeder following the late follicular rise in circulating estradiol (≥100 pg/ml). The presence of sperm in the reproductive tract was used to confirm mating. Animals went through up to three successive rounds of mating until they became pregnant, as confirmed by a rise in circulating mCG during the late luteal phase and ultrasound evidence of a gestational sac at Day 30 post-mating (GD30). Placental vascular parameters were also measured at GD30. Metabolic measurements consisted of fasting levels of blood glucose and insulin at approximately GD30, 60, 90 and 115, as well as an intravenous (iv) glucose tolerance test (GTT) at GD115. MAIN RESULTS AND THE ROLE OF CHANCE: While all animals in the C and T groups eventually became pregnant, T-treated females on average had a greater interval to achieve pregnancy (P < 0.05). However, only ~70% of animals in the WSD and T + WSD groups became pregnant (P < 0.004). One pregnancy in T + WSD group resulted in an anembryonic pregnancy which miscarried around GD60, while another T + WSD female conceived with a rare identical twin pregnancy which required cessation due to impending fetal loss at GD106. Thus, the number of viable fetuses was less in the T + WSD group, compared to C, T or WSD. Placental blood volume at GD30 was reduced in all treatments compared to the C group (P < 0.05). Maternal P4 levels were elevated in the WSD (P < 0.03) group and E2 levels were elevated in T + WSD animals (P < 0.05). An increase in serum A4 levels throughout gestation was observed in all groups (P < 0.03) except WSD (P = 0.3). All groups displayed increased insulin resistance with pregnancy, as measured from the ivGTT during pregnancy. However, only the T + WSD group had a significant increase in fasting glucose levels and glucose clearance during the GTT indicating a worsened glucose tolerance. WSD treatment decreased female fetuses third trimester weights, but there was an interaction between WSD and T to increase female fetal weight when normalized to maternal weight. LARGE SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: The small number of pregnancies in the WSD and T + WSD groups hampers the ability to make definitive conclusions on effects during gestation. Also, the high fertility rate in the controls indicates the cohort was at their breeding prime age, which may impair the ability to observe subtle fertility defects. The low number of fetuses used for male and female analysis requires additional studies. WIDER IMPLICATIONS OF THE FINDINGS: The current findings strongly suggest that both hyperandrogenemia and obesity have detrimental effects on fertility and gestation in primates, which may be directly relevant to women with polycystic ovary syndrome. STUDY FUNDING/COMPETING INTEREST(S): All ONPRC Cores and Units were supported by NIH Grant P51 OD011092 awarded to ONPRC. Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH) under Award Number P50HD071836 (to R.L.S.). The authors have no competing conflict of interests to disclose.


Subject(s)
Diet, Western , Fertility/physiology , Hyperandrogenism/complications , Metabolic Syndrome/complications , Sexual Maturation/physiology , Testosterone/blood , Animals , Female , Hyperandrogenism/blood , Hyperandrogenism/physiopathology , Insulin Resistance/physiology , Macaca , Metabolic Syndrome/blood , Metabolic Syndrome/physiopathology , Pregnancy
9.
Eur Cell Mater ; 34: 128-141, 2017 09 20.
Article in English | MEDLINE | ID: mdl-28929469

ABSTRACT

Tissue engineering-based therapies targeting cartilage diseases, such as osteoarthritis, require in vitro expansion of articular chondrocytes. A major obstacle for these therapies is the dedifferentiation and loss of phenotype accompanying chondrocyte expansion. Recent studies suggest that manipulation of hedgehog signalling may be used to promote chondrocyte re-differentiation. Hedgehog signalling requires the primary cilium, a microtubule-based signalling compartment, the integrity of which is linked to the cytoskeleton. We tested the hypothesis that alterations in cilia expression occurred as consequence of chondrocyte dedifferentiation and influenced hedgehog responsiveness. In vitro chondrocyte expansion to passage 5 (P5) was associated with increased actin stress fibre formation, dedifferentiation and progressive loss of primary cilia, compared to primary (P0) cells. P5 chondrocytes exhibited ~50 % fewer cilia with a reduced mean length. Cilia loss was associated with disruption of ligand-induced hedgehog signalling, such that P5 chondrocytes did not significantly regulate the expression of hedgehog target genes (GLI1 and PTCH1). This phenomenon could be recapitulated by applying 24 h cyclic tensile strain, which reduced cilia prevalence and length in P0 cells. LiCl treatment rescued cilia loss in P5 cells, partially restoring hedgehog signalling, so that GLI1 expression was significantly increased by Indian hedgehog. This study demonstrated that monolayer expansion disrupted primary cilia structure and hedgehog signalling associated with chondrocyte dedifferentiation. This excluded the possibility to use hedgehog ligands to stimulate re-differentiation without first restoring cilia expression. Furthermore, primary cilia loss during chondrocyte expansion would likely impact other cilia pathways important for cartilage health and tissue engineering, including transforming growth factor (TGF), Wnt and mechanosignalling.


Subject(s)
Chondrocytes/cytology , Cilia/metabolism , Hedgehog Proteins/metabolism , Signal Transduction , Actins/metabolism , Animals , Cartilage, Articular/cytology , Cattle , Cell Dedifferentiation/drug effects , Cell Proliferation/drug effects , Chondrocytes/drug effects , Chondrocytes/metabolism , Ligands , Lithium Chloride/pharmacology , Phenotype , Polymerization , Signal Transduction/drug effects , Weight-Bearing
10.
J Ovarian Res ; 10(1): 41, 2017 Jul 06.
Article in English | MEDLINE | ID: mdl-28683759

ABSTRACT

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is a disorder associated with elevated serum VEGFA following chorionic gonadotropin (hCG) exposure in controlled ovarian stimulation (COS) cycles in women. In this study, we tested the effect of intravenous VEGFA neutralization on OHSS-like symptoms and vascular function in rhesus macaques during COS cycles. METHODS: Monkeys (n = 8) were treated with 3 COS protocols and assigned randomly to groups as follows: 1) COS alone (Control, n = 5); 2) COS + VEGF mAb Avastin 19 ± 5 h before hCG (Avastin pre-hCG; n = 6); 3) COS + Avastin 3-4 days post-hCG (Avastin post-hCG; n = 4); 4) COS + Simulated Early Pregnancy (SEP n = 3); or 5) COS + SEP + Avastin (SEP + Avastin n = 3). Follicles were aspirated 36 h post-hCG, fluid was collected from one follicle for analysis of steroid and vascular hormone content. Remaining follicles were aspirated, and luteinized granulosa cells (LGCs) cultured for 24 h. Ovarian/uterine vascular flow (VF) and blood volume (BV) were analyzed by contrast enhanced ultrasound (CEUS) before hCG bolus and 6-8 days post-hCG bolus/time of peak SEP response. Ovarian permeability to albumin was analyzed by Dynamic Contrast Enhanced-MRI (DCE-MRI) post-hCG. RESULTS: Abdominal fluid was present in 4/5 Control, 2/6 Avastin pre-hCG, and 3/4 Avastin post-hCG females. Neutralization of VEGFA before hCG reduced ovarian VF, BV, and permeability to albumin (P < 0.05), while only ovarian VF and permeability were reduced in Avastin-post hCG group (P < 0.05). There was no effect of Avastin on ovarian vascular function during COS + SEP. VEGF levels in follicular fluid were reduced 78-fold by Avastin pre-hCG, and LGCs exposed to Avastin in vivo also released 4-fold less VEGF into culture media (P < 0.05). Culture medium of LGCs exposed to VEGFA neutralization in vivo had lower levels of P4 and ANGPT1, and an increased ratio of ANGPT2/1 (P < 0.05). Uterine VF was reduced by SEP + Avastin in the basalis/junctional zone (P < 0.05). CONCLUSIONS: Avastin treatment before hCG prevents the development of symptoms associated with ovarian hyperstimulation syndrome. In vitro data suggest neutralization of VEGFA alters expression of other vascular factors typically induced by hCG in the luteinizing follicle. Neutralization of VEGFA action alters the vascular function of the basalis zone of the uterus during simulated early pregnancy, indicating a potential effect on embryo implantation.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Bevacizumab/administration & dosage , Capillary Permeability/drug effects , Ovarian Hyperstimulation Syndrome/metabolism , Ovary/drug effects , Ovary/metabolism , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Animals , Chorionic Gonadotropin/adverse effects , Contrast Media , Female , Humans , Image Enhancement , Macaca mulatta , Magnetic Resonance Imaging , Menstrual Cycle , Ovarian Follicle/drug effects , Ovarian Follicle/metabolism , Ovarian Hyperstimulation Syndrome/diagnostic imaging , Ovarian Hyperstimulation Syndrome/pathology , Ovarian Hyperstimulation Syndrome/prevention & control , Ovulation Induction , Pregnancy
11.
Gene Ther ; 24(9): 534-538, 2017 09.
Article in English | MEDLINE | ID: mdl-28467402

ABSTRACT

Approval of Spinraza (nusinersen) for treatment of spinal muscular atrophy prompts consideration of a number of ethical issues that arise whenever a new treatment is proposed for a serious condition, especially one that is rare and can devastatingly affect children. Patients, families, clinicians, researchers, institutions and policymakers all must take account of the ways that newly available treatments affect informed and shared decision-making about therapeutic and research options. The issues to consider include: addressing what is still uncertain and unknown; the possibility that potential benefits will be exaggerated and potential harms underemphasized in the media, by advocacy organizations, and in consent forms and processes; the high cost of many novel drugs and biologics; the effects of including conditions of variable phenotype in state-mandated newborn screening panels; and how new treatments can change the standard of care, altering what is and is not known about a disorder and posing challenges for decision-making at both individual and policy levels. The good news that Spinraza brings thus requires additional attention to its ethical and policy implications, to improve counseling and shared decision-making about treatment and research options for patients and all involved in their care.


Subject(s)
Genetic Therapy/ethics , Muscular Atrophy, Spinal/therapy , Costs and Cost Analysis , Genetic Therapy/economics , Genetic Therapy/legislation & jurisprudence , Genetic Therapy/psychology , Health Knowledge, Attitudes, Practice , Humans , Muscular Atrophy, Spinal/genetics , Oligonucleotides/administration & dosage
12.
Clin Genet ; 91(1): 137-140, 2017 01.
Article in English | MEDLINE | ID: mdl-27392285

ABSTRACT

Genome wide sequencing is an emerging clinical tool that may provide information on genetic variants that are not directly related to the patient's primary disorder. These incidental findings (IFs) may include information about conditions that can be treated and may also indicate conditions for which treatments are not currently available. Data is currently limited regarding what IFs an individual would want to disclose. This study reports on 305 individual choices for return of IFs that were completed at the Medical College of Wisconsin's clinical sequencing laboratory. Individuals were given access to five categories of IFs to select from: no incidental findings, untreatable childhood disorders, treatable adulthood disorders, untreatable adulthood disorders, and carrier of a disorder. Retrospective chart review was conducted and individual choices were recorded and analyzed. The majority of individuals (76.1%) selected every IF to be reported, 14.4% wanted a subset of the options, and 9.5% did not want any IFs reported. This study contributes to the limited data that demonstrates what an individual would actually choose when undergoing genetic sequencing. Furthermore, this data supports the opinion that individuals want and utilize the ability to choose the findings reported.


Subject(s)
Choice Behavior/ethics , Disclosure/ethics , Genome, Human/genetics , Incidental Findings , Sequence Analysis, DNA/methods , Adolescent , Adult , Child , Genetic Testing/ethics , Genetic Testing/methods , Genetics, Medical/ethics , Genetics, Medical/methods , Humans , Retrospective Studies
13.
Accid Anal Prev ; 98: 241-251, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27770690

ABSTRACT

BACKGROUND: Alcohol contributes to approximately 30% of all serious crashes. While the majority of drivers acknowledge the risks associated with drink-driving, a significant proportion of the population continue to engage in this behaviour. Attitudes towards drink-driving as well as personal alcohol consumption patterns are likely to underpin a driver's decision to drink-drive. These associations were explored in the current study. METHODS: A large (N=2994) cross-sectional online survey of a representative sample of drivers in Australia was conducted. Participants provided information about their own alcohol consumption patterns, drink-driving behaviour as well as attitudes towards drink-driving (own and others) and enforcement strategies. RESULTS: Alcohol consumption patterns differed according to age, gender and work status. Drivers who reported drink-driving behaviour and had high risk alcohol consumption patterns were less likely to agree that drink-driving leads to increased crash risk and more likely to agree they drink and drive when they believed they could get away with it. In contrast, drivers who did not report drink-driving and had low risk consumption patterns were more likely to report that the enforcement strategies are too lenient. Binary logistic regression showed that high risk alcohol consumption patterns and agreement from drivers that they drink and drive when they believe they can get away with it had the strongest associations with drink-driving. These findings highlight the relationships between one's drinking patterns, drink-drive behaviour and attitudes towards drink-driving and drink-driving enforcement CONCLUSIONS AND IMPLICATIONS: The patterns of associations that emerged suggest that drink-driving is the expression of a broader health issue for the most "at-risk" cohort of drinkers. The decision to drink and drive may result from a need borne from an alcohol dependent lifestyle exacerbated by a social acceptability of the behaviour and positive attitudes towards one's ability to drink-drive with few adverse consequences. Therefore, the broader alcohol consumption patterns of drink-drivers needs to be considered when targeting drink-drive reductions.


Subject(s)
Accidents, Traffic/statistics & numerical data , Alcohol Drinking/epidemiology , Automobile Driving/statistics & numerical data , Dangerous Behavior , Adult , Aged , Alcoholic Intoxication/epidemiology , Australia/epidemiology , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Risk-Taking , Safety , Social Environment , Young Adult
14.
Hum Reprod ; 31(7): 1522-30, 2016 07.
Article in English | MEDLINE | ID: mdl-27165618

ABSTRACT

STUDY QUESTION: What are the direct effects and physiological role of anti-Müllerian hormone (AMH) during primate follicular development and function at specific stages of folliculogenesis? SUMMARY ANSWER: AMH actions in the primate ovary may be stage-dependent, directly promoting pre-antral follicle growth while inhibiting antral follicle maturation and dominant follicle selection. WHAT IS KNOWN ALREADY: AMH is expressed in the adult ovary, particularly in developing follicles. Studies in mice suggest that AMH suppresses pre-antral follicle growth in vitro, and inhibits primordial follicle recruitment and FSH-stimulated antral follicle steroidogenesis. STUDY DESIGN, SIZE, DURATION: For in vitro study, secondary follicles were isolated from ovaries of 12 rhesus macaques and cultured for 5 weeks. For in vivo study, intraovarian infusion was conducted on five monkeys for the entire follicular phase during two spontaneous menstrual cycles. PARTICIPANTS/MATERIALS, SETTING, METHODS: For in vitro study, individual follicles were cultured in a 5% O2 environment, in alpha minimum essential medium supplemented with recombinant human FSH. Follicles were randomly assigned to treatments of recombinant human AMH protein or neutralizing anti-human AMH antibody (AMH-Ab). Follicle survival, growth, steroid production, steroidogenic enzyme expression, and oocyte maturation were assessed. For in vivo study, ovaries were infused with control vehicle or AMH-Ab during the follicular phase of the menstrual cycle. Cycle length, serum steroid levels, and antral follicle growth were evaluated. MAIN RESULTS AND THE ROLE OF CHANCE: AMH exposure during culture weeks 0-3 (pre-antral stage) promoted, while AMH-Ab delayed, antrum formation of growing follicles compared with controls. AMH treatment during culture weeks 3-5 (antral stage) decreased (P < 0.05) estradiol (E2) production, as well as the mRNA expression of cytochrome P450 family 19 subfamily A polypeptide 1, by antral follicles relative to controls, whereas AMH-Ab increased (P < 0.05) follicular mRNA levels of the enzyme. Intraovarian infusion of AMH-Ab during the follicular phase of the menstrual cycle increased (P < 0.05) the average levels of serum E2 compared with those of the control cycles. Three of the five AMH-Ab-treated ovaries displayed multiple (n = 2-9) medium-to-large (2-8 mm) antral follicles at the mid-cycle E2 peak, whereas only one large (4-7 mm) antral follicle was observed in all monkeys during their control cycles. The average levels of serum progesterone were higher (P < 0.05) during the luteal phase of cycles following the AMH-Ab infusion relative to the vehicle infusion. LIMITATIONS, REASONS FOR CAUTION: The in vitro study of AMH actions on cultured individual macaque follicles was limited to the interval from the secondary to small antral stage. A sequential study design was used for in vivo experiments, which may limit the power of the study. WIDER IMPLICATIONS OF THE FINDINGS: The current study provides novel information on direct actions and role of AMH during primate follicular development, and selection of a dominant follicle by the late follicular phase of the menstrual cycle. We hypothesize that AMH acts positively on follicular growth during the pre-antral stage in primates, but negatively impacts antral follicle maturation, which is different from what is reported in the mouse model. STUDY FUNDING/COMPETING INTERESTS: NIH NICHD R01HD082208, NIH ORWH/NICHD K12HD043488 (BIRCWH), NIH OD P51OD011092 (ONPRC), Collins Medical Trust. There are no conflicts of interest. TRIAL REGISTRATION NUMBER: Not applicable.


Subject(s)
Anti-Mullerian Hormone/pharmacology , Ovarian Follicle/drug effects , Animals , Anti-Mullerian Hormone/blood , Anti-Mullerian Hormone/immunology , Antibodies, Neutralizing/pharmacology , Cytochrome P450 Family 19/metabolism , Estradiol/biosynthesis , Female , Macaca mulatta , Ovarian Follicle/growth & development , Progesterone/blood , RNA, Messenger/metabolism , Random Allocation , Tissue Culture Techniques
15.
J Homosex ; 63(8): 1086-126, 2016 Aug.
Article in English | MEDLINE | ID: mdl-26566991

ABSTRACT

Discrimination against sexual minorities is widespread and has deleterious consequences on victims' psychological and physical wellbeing. However, a review of the psychometric properties of instruments measuring lesbian, gay, and bisexual (LGB) discrimination has not been conducted. The results of this review, which involved evaluating 162 articles, reveal that most have suboptimal psychometric properties. Specifically, myriad scales possess questionable content validity as (1) items are not created in collaboration with sexual minorities; (2) measures possess a small number of items and, thus, may not sufficiently represent the domain of interest; and (3) scales are "adapted" from measures designed to examine race- and gender-based discrimination. Additional limitations include (1) summed scores are computed, often in the absence of scale score reliability metrics; (2) summed scores operate from the questionable assumption that diverse forms of discrimination are necessarily interrelated; (3) the dimensionality of instruments presumed to consist of subscales is seldom tested; (4) tests of criterion-related validity are routinely omitted; and (5) formal tests of measures' construct validity are seldom provided, necessitating that one infer validity based on the results obtained. The absence of "gold standard" measures, the attendant difficulty in formulating a coherent picture of this body of research, and suggestions for psychometric improvements are noted.


Subject(s)
Bisexuality , Homophobia/psychology , Homosexuality , Sexual and Gender Minorities , Female , Humans , Male , Psychometrics/methods , Reproducibility of Results , Social Stigma
16.
Neuroscience ; 310: 12-26, 2015 Dec 03.
Article in English | MEDLINE | ID: mdl-26363150

ABSTRACT

Treatment of Parkinson's disease (PD) with dopamine replacement relieves symptoms of poverty of movement, but often causes drug-induced dyskinesias. Accumulating clinical and pre-clinical evidence suggests that the primary motor cortex (M1) is involved in the pathophysiology of PD and that modulating cortical activity may be a therapeutic target in PD and dyskinesia. However, surprisingly little is known about how M1 neurotransmitter tone or gene expression is altered in PD, dyskinesia or associated animal models. The present study utilized the rat unilateral 6-hydroxydopamine (6-OHDA) model of PD/dyskinesia to characterize structural and functional changes taking place in M1 monoamine innervation and gene expression. 6-OHDA caused dopamine pathology in M1, although the lesion was less severe than in the striatum. Rats with 6-OHDA lesions showed a PD motor impairment and developed dyskinesia when given L-DOPA or the D1 receptor agonist, SKF81297. M1 expression of two immediate-early genes (c-Fos and ARC) was strongly enhanced by either L-DOPA or SKF81297. At the same time, expression of genes specifically involved in glutamate and GABA signaling were either modestly affected or unchanged by lesion and/or treatment. We conclude that M1 neurotransmission and signal transduction in the rat 6-OHDA model of PD/dyskinesia mirror features of human PD, supporting the utility of the model to study M1 dysfunction in PD and the elucidation of novel pathophysiological mechanisms and therapeutic targets.


Subject(s)
AIDS-Related Complex/metabolism , Dyskinesia, Drug-Induced/pathology , Gene Expression/physiology , Motor Cortex/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Synaptic Transmission/physiology , AIDS-Related Complex/genetics , Animals , Benzazepines/adverse effects , Disease Models, Animal , Dopamine Agents/adverse effects , Dyskinesia, Drug-Induced/etiology , Functional Laterality/drug effects , Gene Expression/drug effects , Levodopa/therapeutic use , Male , Medial Forebrain Bundle/injuries , Oxidopamine/toxicity , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/drug therapy , Proto-Oncogene Proteins c-fos/genetics , Rats , Rats, Sprague-Dawley , Severity of Illness Index , Synaptic Transmission/drug effects
17.
Chem Commun (Camb) ; 51(60): 12134-7, 2015 Aug 04.
Article in English | MEDLINE | ID: mdl-26126593

ABSTRACT

Principal component analysis was applied to a biomaterial library of poly(beta-amino ester)s, useful for non-viral gene delivery, to elucidate chemical parameters that drive biological function. Correlative relationships and principal components were analyzed between 24 physico-chemical polymer properties and 3 cell-based functional variables in human glioblastoma cells (transfection, uptake, and viability).


Subject(s)
Biocompatible Materials/chemistry , DNA/administration & dosage , Gene Transfer Techniques , Polymers/chemistry , Principal Component Analysis , Biocompatible Materials/metabolism , Cell Line, Tumor , Humans , Polymers/metabolism , Transfection
18.
Science ; 347(6219): 250-4, 2015 Jan 16.
Article in English | MEDLINE | ID: mdl-25593180

ABSTRACT

The physiological and biomechanical requirements of flight at high altitude have been the subject of much interest. Here, we uncover a steep relation between heart rate and wingbeat frequency (raised to the exponent 3.5) and estimated metabolic power and wingbeat frequency (exponent 7) of migratory bar-headed geese. Flight costs increase more rapidly than anticipated as air density declines, which overturns prevailing expectations that this species should maintain high-altitude flight when traversing the Himalayas. Instead, a "roller coaster" strategy, of tracking the underlying terrain and discarding large altitude gains only to recoup them later in the flight with occasional benefits from orographic lift, is shown to be energetically advantageous for flights over the Himalayas.


Subject(s)
Altitude , Animal Migration , Energy Metabolism , Flight, Animal/physiology , Geese/physiology , Wings, Animal/physiology , Animals , Biomechanical Phenomena , Body Temperature , Body Weight , Heart Rate , Tibet
19.
Br J Pharmacol ; 172(1): 119-30, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25175895

ABSTRACT

BACKGROUND AND PURPOSE: Treatment of Parkinson's disease (PD) with L-DOPA eventually causes abnormal involuntary movements known as dyskinesias in most patients. Dyskinesia can be reduced using compounds that act as direct or indirect agonists of the 5-HT1 A receptor, but these drugs have been reported to worsen PD features and are known to produce '5-HT syndrome', symptoms of which include tremor, myoclonus, rigidity and hyper-reflexia. EXPERIMENTAL APPROACH: Sprague-Dawley rats were given unilateral nigrostriatal dopamine lesions with 6-hydroxydopamine. Each of the following three purportedly anti-dyskinetic 5-HT compounds were administered 15 min before L-DOPA: the full 5-HT1 A agonist ±-8-hydroxy-2-dipropylaminotetralin (±8-OH-DPAT), the partial 5-HT1 A agonist buspirone or the 5-HT transporter inhibitor citalopram. After these injections, animals were monitored for dyskinesia, 5-HT syndrome, motor activity and PD akinesia. KEY RESULTS: Each 5-HT drug dose-dependently reduced dyskinesia by relatively equal amounts (±8-OH-DPAT ≥ citalopram ≥ buspirone), but 5-HT syndrome was higher with ±8-OH-DPAT, lower with buspirone and not present with citalopram. Importantly, with or without L-DOPA, all three compounds provided an additional improvement of PD akinesia. All drugs tempered the locomotor response to L-DOPA suggesting dyskinesia reduction, but vertical rearing was reduced with 5-HT drugs, potentially reflecting features of 5-HT syndrome. CONCLUSIONS AND IMPLICATIONS: The results suggest that compounds that indirectly facilitate 5-HT1 A receptor activation, such as citalopram, may be more effective therapeutics than direct 5-HT1 A receptor agonists because they exhibit similar anti-dyskinesia efficacy, while possessing a reduced side effect profile.


Subject(s)
8-Hydroxy-2-(di-n-propylamino)tetralin/therapeutic use , Buspirone/therapeutic use , Citalopram/therapeutic use , Dyskinesia, Drug-Induced/drug therapy , Parkinson Disease/drug therapy , Serotonin 5-HT1 Receptor Agonists/therapeutic use , Animals , Antiparkinson Agents , Dyskinesia, Drug-Induced/physiopathology , Levodopa , Male , Parkinson Disease/physiopathology , Psychomotor Performance , Rats, Sprague-Dawley , Receptor, Serotonin, 5-HT1A/physiology
20.
Sci Rep ; 4: 6229, 2014 Aug 29.
Article in English | MEDLINE | ID: mdl-25169735

ABSTRACT

Parametric fluctuations or stochastic signals are introduced into the rectangular pulse sequence to investigate the feasibility of random dynamical decoupling. In a large parameter region, we find that the out-of-order control pulses work as well as the regular pulses for dynamical decoupling and dissipation suppression. Calculations and analysis are enabled by and based on a nonperturbative dynamical decoupling approach allowed by an exact quantum-state-diffusion equation. When the average frequency and duration of the pulse sequence take proper values, the random control sequence is robust, fault-tolerant, and insensitive to pulse strength deviations and interpulse temporal separation in the quasi-periodic sequence. This relaxes the operational requirements placed on quantum control devices to a great deal.

SELECTION OF CITATIONS
SEARCH DETAIL
...